(Q38738913)

6 September 2017

1 reference

title

Pharmacokinetics of haloperidol (English)

1 reference

6 September 2017

1 reference

Froemming JS

1

1 reference

6 September 2017

Lam YW

series ordinal

2

1 reference

6 September 2017

Jann MW

series ordinal

3

1 reference

6 September 2017

Davis CM

series ordinal

4

1 reference

6 September 2017

publication date

1 December 1989

1 reference

Clinical Pharmacokinetics

6 September 2017

published in

1 reference

6 September 2017

volume

17

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

396-423

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198917060-00004

6 September 2017

exact match

0 references

cites work

The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population

1 reference

12 December 2020

Rapid Control of Psychotic Excitement States with Intramuscular Haloperidol

1 reference

12 December 2020

Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays

1 reference

12 December 2020

Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients

1 reference

12 December 2020

Clinical response and plasma haloperidol levels in schizophrenia

1 reference

12 December 2020

High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin

1 reference

12 December 2020

Influence of route of administration on haloperidol plasma levels in psychotic patients

1 reference

12 December 2020

Simultaneous determination of haloperidol and its reduced metabolite in serum and plasma by isocratic liquid chromatography with electrochemical detection

1 reference

12 December 2020

Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance

1 reference

12 December 2020

Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients

1 reference

12 December 2020

Pharmacokinetics of haloperidol in psychotic patients

1 reference

12 December 2020

Improved gas chromatographic-mass spectrometric assay for haloperidol utilizing ammonia chemical ionization and selected-ion monitoring

1 reference

12 December 2020

Clinical implications of increased antipsychotic plasma concentrations upon anticonvulsant cessation

1 reference

12 December 2020

Bioavailability of intramuscular versus oral haloperidol in schizophrenic patients

1 reference

12 December 2020

Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects

1 reference

12 December 2020

Effects of carbamazepine on plasma haloperidol levels

1 reference

12 December 2020

Plasma homovanillic acid levels and subtyping of schizophrenia

1 reference

12 December 2020

Theoretical and practical importance of plasma levels of haloperidol. correlations with clinical and computerized EEG data

1 reference

12 December 2020

Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays

1 reference

12 December 2020

Plasma level monitoring of antipsychotic drugs. Clinical utility

1 reference

12 December 2020

Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)

1 reference

12 December 2020

Haloperidol pharmacokinetics: A preliminary study in rhesus monkeys using a new radioimmunoassay procedure

1 reference

12 December 2020

Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia

1 reference

12 December 2020

Quantitative determination of haloperidol in human plasma by high-performance liquid chromatography

1 reference

12 December 2020

Thioridazine and the neuroleptic radioreceptor assay.

1 reference

12 December 2020

Prolonged pharmacologic activity of neuroleptic drugs

1 reference

12 December 2020

Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients.

1 reference

12 December 2020

Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients

1 reference

12 December 2020

Determination of haloperidol in human serum by radioimmunoassay.

1 reference

12 December 2020

Possible interference by the reduced haloperidol metabolite with the radioimmunoassay and radioreceptor assay of blood haloperidol

1 reference

12 December 2020

Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.

1 reference

12 December 2020

Neuroleptic radioreceptor activity and clinical outcome in schizophrenia

1 reference

12 December 2020

Pharmacokinetic studies on haloperidol in man.

1 reference

12 December 2020

Persistence of Haloperidol in the Brain

1 reference

12 December 2020

Measurement of neuroleptic concentrations by GLC and radioreceptor assay

1 reference

12 December 2020

Emergency use of intravenous haloperidol

1 reference

12 December 2020

Reduced Haloperidol/Haloperidol ratio and clinical outcome in schizophrenia: Preliminary evidences

1 reference

12 December 2020

Measurement of haloperidol and reduced haloperidol in human plasma using reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

The non-linear pharmacokinetics of prednisone and prednisolone. I. Theoretical

1 reference

12 December 2020

Haloperidol concentrations elevated in Chinese patients

1 reference

12 December 2020

The interpretation of plasma haloperidol concentrations.

1 reference

12 December 2020

Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms

1 reference

12 December 2020

Haloperidol kinetics after oral and intravenous doses

1 reference

12 December 2020

Pharmacokinetic studies in volunteers of intravenous and oral cis (Z)-flupentixol and intramuscular cis (Z)-flupentixol decanoate in Viscoleo.

1 reference

12 December 2020

Low plasma reduced haloperidol/haloperidol ratios in Chinese patients

1 reference

12 December 2020

Analytical and pharmacokinetic studies on butyrophenones

1 reference

12 December 2020

A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood

1 reference

12 December 2020

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

1 reference

12 December 2020

Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol

1 reference

12 December 2020

Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study

1 reference

12 December 2020

Serum haloperidol levels of schizophrenics receiving treatment for tuberculosis

1 reference

12 December 2020

Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia

1 reference

12 December 2020

Elimination half-life and bioavailability of haloperidol in schizophrenic patients

1 reference

12 December 2020

Carbamazepine as an adjunct of antipsychotic therapy

1 reference

12 December 2020

Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations

1 reference

12 December 2020

Haloperidol plasma level monitoring in neuropsychiatric patients

1 reference

12 December 2020

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

1 reference

12 December 2020

Haloperidol plasma/red blood cell ratios and clinical efficacy

1 reference

12 December 2020

Studies on serum protein binding of haloperidol

1 reference

12 December 2020

Haloperidol concentrations in saliva and serum: determination by the radioimmunoassay method

1 reference

12 December 2020

A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.

1 reference

12 December 2020

Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches

1 reference

12 December 2020

Reduced haloperidol in the post-mortem brains of haloperidol-treated patients

1 reference

12 December 2020

Haloperidol Plasma Level Monitoring in Pediatric Patients

1 reference

12 December 2020

Electrophysiological interactions between haloperidol and reduced haloperidol, and dopamine, norepinephrine and phencyclidine in rat brain.

1 reference

12 December 2020

Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?

1 reference

12 December 2020

Haloperidol dose, plasma levels, and clinical response: a double-blind study [proceedings]

1 reference

12 December 2020

Plasma levels of haloperidol and clinical response

1 reference

12 December 2020

Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.

1 reference

12 December 2020

The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients

1 reference

12 December 2020

Effect of carbamazepine on neuroleptic plasma levels and efficacy

1 reference

12 December 2020

Lithium and haloperidol

1 reference

12 December 2020

Rapid formation of reduced haloperidol in guinea pigs following haloperidol administration.

1 reference

12 December 2020

Adverse reactions in treatment with lithium carbonate and haloperidol

1 reference

12 December 2020

Plasma level profile of haloperidol in man following intramuscular administration

1 reference

12 December 2020

Relationship of serum haloperidol levels to clinical response in schizophrenic patients

1 reference

12 December 2020

Sensitive electrochemical high-performance liquid chromatography assay for the simultaneous determination of haloperidol and reduced haloperidol

1 reference

12 December 2020

A new radioimmunoassay for haloperidol: direct measurement of serum and striatal concentrations

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in guinea pigs

1 reference

12 December 2020

Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?

1 reference

12 December 2020

Pharmacokinetics of haloperidol decanoate. A 2-year follow-up

1 reference

12 December 2020

Prolactin releasing potencies of antipsychotic and related nonantipsychotic compounds in female rats: relation to clinical potencies

1 reference

12 December 2020

Isolation and Identification of a Metabolite of Haloperidol

1 reference

12 December 2020

Blood Levels of Neuroleptic Drugs in Nonresponding Chronic Schizophrenic Patients

1 reference

12 December 2020

Haloperidol pharmacokinetics following gastric bypass surgery

1 reference

12 December 2020

A comparison of dopamine receptor blocking assay with plasma drug levels of haloperidol in schizophrenic patients

1 reference

12 December 2020

Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy

1 reference

12 December 2020

Reduced haloperidol: Effects on striatal dopamine metabolism and conversion to haloperidol in the rat

1 reference

12 December 2020

Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis

1 reference

12 December 2020

Reduced haloperidol and haloperidol: effects on homovanillic acid in caudate and prefrontal cortex.

1 reference

12 December 2020

Behavioral prediction of response to haloperidol: a test dose strategy

1 reference

12 December 2020

High-performance liquid chromatographic determination of haloperidol in plasma

1 reference

12 December 2020

Basic principles of rapid neuroleptization

1 reference

12 December 2020

Pharmacokinetic studies on flupenthixol and flupenthixol decanoate in man using tritium labelled compounds

1 reference

12 December 2020

Clinical pharmacokinetics of the depot antipsychotics

1 reference

12 December 2020

Haloperidol determination in serum and cerebrospinal fluid using gas--liquid chromatography with nitrogen--phosphorus detection: application to pharmacokinetic studies

1 reference

12 December 2020

Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin

1 reference

12 December 2020

The Long-Acting Phenothiazines

1 reference

12 December 2020

Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration

1 reference

12 December 2020

The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol

1 reference

12 December 2020

Serum haloperidol determinations in psychiatric patients. Comparison of methods and correlation with serum prolactin level

1 reference

12 December 2020

Serum level of haloperidol and its clinical significance

1 reference

12 December 2020

Effect of anticonvulsants on plasma haloperidol and thioridazine levels

1 reference

12 December 2020

Serum haloperidol concentrations and clinical response in acute psychosis

1 reference

12 December 2020

Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring

1 reference

12 December 2020

Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patients

1 reference

12 December 2020

Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro

1 reference

12 December 2020

Neuroendocrine Tests during Treatment with Neuroleptic Drugs. I. Plasma Prolactin Response to Haloperidol Challenge

1 reference

12 December 2020

The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits

1 reference

12 December 2020

Concurrent lithium administration results in higher haloperidol levels in brain and plasma of guinea pigs.

1 reference

12 December 2020

Haloperidol levels and clinical response

1 reference

12 December 2020

Review of haloperidol blood level and clinical response: looking through the window

1 reference

12 December 2020

Interconversion between haloperidol and reduced haloperidol in humans

1 reference

12 December 2020

Lithium Carbonate, Haloperidol, and Irreversible Brain Damage

1 reference

12 December 2020

RBC and plasma levels of haloperidol and clinical response in schizophrenia

1 reference

12 December 2020

Blood levels of haloperidol in schizophrenic patients

1 reference

12 December 2020

An ultrasensitive method for the measurement of haloperidol and reduced haloperidol in plasma by high-performance liquid chromatography with coulometric detection

1 reference

12 December 2020

Use of carbamazepine in psychiatric disorders.

1 reference

12 December 2020

Therapeutic drug monitoring of psychotropic drugs in children

1 reference

12 December 2020

Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital.

1 reference

12 December 2020

Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.

1 reference

12 December 2020

Short-term haloperidol administration acutely elevates human plasma homovanillic acid concentration

1 reference

12 December 2020

Haloperidol plasma and red blood cell levels and clinical antipsychotic response

1 reference

12 December 2020

Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs

1 reference

12 December 2020

Interconversions of haloperidol and reduced haloperidol in guinea pig and rat liver microsomes

1 reference

12 December 2020

Haloperidol binding to monoclonal antibodies: conformational analysis and relationships to D-2 receptor binding.

1 reference

12 December 2020

Haloperidol and prolactin concentrations in Asians and Caucasians

1 reference

12 December 2020

Relationship between prolactin response and antipsychotic effect of thioridazine in psychiatric patients

1 reference

12 December 2020

The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients

1 reference

12 December 2020

1 reference

12 December 2020

10.2165/00003088-198917060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1001427776

0 references

1 reference